Ipca tumbles on quality concerns at Indian site
This article was originally published in Scrip
Executive Summary
Shares of the Indian generics company, Ipca Laboratories, tumbled after it said that it had voluntarily referred certain quality "non-conformances" at its Indore facility to the US FDA.